InFlectis BioScience: Reportable, Inc.: InFlectis BioScience Expands Leadership Team with Three Experienced International Appointments: Mark Pykett Is Appointed Chairman, Batrice Lejeune Is Appointed Chief Regulatory Officer, and Prof. Brian Popko Joins Scientific Advisory Bo
Nantes, France--(Newsfile Corp. - October 4, 2021) - InFlectis BioScience SAS, a clinical-stage company developing innovative therapeutics for neuromuscular diseases by harnessing the Integrated S...
Read full article »
InFlectis is a France-based biotechnology company that researches and develops small molecule therapies for the treatment of neuromuscular diseases.
Read more